Managing lung cancer in idiopathic pulmonary fibrosis patients is difficult, largely because standard lung cancer treatments create a risk of IPF exacerbations and patients dying early. An Italian study that covered four patients suggests that Boehringer Ingelheim’s Ofev (nintedanib) could be an answer. The research, “Lung Cancer in Patients with…
Ofev Could Be Used to Treat Pulmonary Fibrosis Patients’ Lung Cancer, Study Reports
The Pulmonary Fibrosis Foundation has a list of the all of the medical centers in the U.S. that have the expertise to treat patients with pulmonary fibrosis (PF), along with links to the centers’ websites so they can be contacted easily. The list can be searched by…
As much as I desperately want to be involved in my friends’ social lives and participate in work events, charity fundraisers, and milestone celebrations such as weddings, stag and does, and baby showers, I find that lately, I have been feeling the stress of obligations. What is…
Managing a chronic illness can be difficult. There are many different medications to take (often at different times), appointments to remember, symptoms to keep track of, and lots of information to absorb. Thankfully, living in a digital age means that there are numerous mobile apps that can help you manage…
Combining genetic analysis and machine learning can improve the identification value of biopsies used to detect pneumonia that progressively scars lungs — a classic marker of pulmonary fibrosis — without doctors having to resort to surgery, according to a study. The findings apply to the transbronchial biopsies, or TBBs, that doctors…
Keeping yourself healthy can feel impossible sometimes, especially if you have pulmonary fibrosis (PF). However, the Pulmonary Fibrosis Foundation suggests a few lifestyle changes that can improve your quality of life. 1. Exercise You may feel tempted to exercise as little as possible to avoid feeling short of breath or…
Clinical trials of idiopathic pulmonary fibrosis (IPF) therapies should include measures that reflect patients’ views of the success of treatments, Columbia University Medical Center researchers contend. In particular, the trials should add reduction in respiratory-related hospitalizations to their measurement tool kit, the team said. Patients’ views of treatment success could influence…
The European Commission (EC) recently approved a new formulation of Esbriet (pirfenidone) tablets for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF). According to Roche, Esbriet’s developer, the new tablet formulation will reduce the number of pills patients need to take throughout the day, offering patients an easier…
We tend to take our lungs for granted, that is until we develop breathing difficulties. But even when living with a chronic lung disease, it is even more important to look after these vital organs as best we can. The Rush University Medical Center has some…
Life can be extremely difficult when you’re coping with a chronic lung disease like pulmonary fibrosis (PF). As well as dealing with the physical effects of the disease, you also have to cope with the emotional fallout that comes with living with PF. MORE: The realities of a pulmonary fibrosis…
